Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$686M |
| 2 |
Merck
MRK
|
+$536M |
| 3 |
GoDaddy
GDDY
|
+$330M |
| 4 |
CSX Corp
CSX
|
+$227M |
| 5 |
Aramark
ARMK
|
+$217M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$372M |
| 2 |
DexCom
DXCM
|
+$339M |
| 3 |
Broadcom
AVGO
|
+$321M |
| 4 |
Adobe
ADBE
|
+$280M |
| 5 |
Meta Platforms (Facebook)
META
|
+$273M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.38% |
| 2 | Healthcare | 16.14% |
| 3 | Financials | 13.58% |
| 4 | Industrials | 12.86% |
| 5 | Consumer Discretionary | 11.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SCG
1226
DELISTED
Scana
SCG
| $1.36M | ﹤0.01% |
34,876
-700
| -2% | -$26.8K |
|
1227
Reliance Steel & Aluminium
RS
$20.8B
| $1.35M | ﹤0.01% |
15,800
+6,800
| +76% | +$602K |
|
1228
Ingersoll Rand
IR
$33B
| $1.32M | ﹤0.01% |
46,700
-46,900
| -50% | -$1.31M |
|
|
MPT
1229
Medical Properties Trust
MPT
$2.92B
| $1.29M | ﹤0.01% |
86,500
+54,400
| +169% | +$793K |
|
|
SODA
1230
DELISTED
SodaStream International Ltd
SODA
| $1.29M | ﹤0.01% |
9,086
+3,649
| +67% | +$439K |
|
1231
Match Group
MTCH
$9.03B
| $1.27M | ﹤0.01% |
21,976
+11,738
| +115% | +$550K |
|
1232
Columbia Sportswear
COLM
$3.18B
| $1.26M | ﹤0.01% |
+13,500
| New | +$1.23M |
|
1233
Vanguard International High Dividend Yield ETF
VYMI
$20.3B
| $1.24M | ﹤0.01% |
19,655
+4,923
| +33% | +$310K |
|
1234
Huazhu Hotels Group
HTHT
$12.8B
| $1.23M | ﹤0.01% |
+38,100
| New | +$1.34M |
|
1235
Vanguard High Dividend Yield ETF
VYM
$81.3B
| $1.19M | ﹤0.01% |
13,690
+5,464
| +66% | +$473K |
|
1236
Antero Resources
AR
$10.6B
| $1.16M | ﹤0.01% |
65,519
+18,526
| +39% | +$359K |
|
1237
AGCO
AGCO
$8.67B
| $1.15M | ﹤0.01% |
18,876
-2,700
| -13% | -$163K |
|
1238
Qualys
QLYS
$4.79B
| $1.14M | ﹤0.01% |
12,798
+6,847
| +115% | +$616K |
|
1239
Healthcare Realty
HR
$7.51B
| $1.13M | ﹤0.01% |
42,539
+15,601
| +58% | +$430K |
|
1240
Kirby Corp
KEX
$7.77B
| $1.13M | ﹤0.01% |
13,700
+5,700
| +71% | +$478K |
|
1241
National Health Investors
NHI
$3.86B
| $1.12M | ﹤0.01% |
14,872
+122
| +0.8% | +$9.32K |
|
1242
Itaú Unibanco
ITUB
$92B
| $1.08M | ﹤0.01% |
202,152
-826,111
| -80% | -$4.44M |
|
|
TRCO
1243
DELISTED
TRIBUNE MEDIA COMPANY CLASS A
TRCO
| $1.07M | ﹤0.01% |
27,900
-68,400
| -71% | -$2.46M |
|
1244
SM Energy
SM
$7.49B
| $1.07M | ﹤0.01% |
+33,800
| New | +$970K |
|
|
ATH
1245
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
| $1.04M | ﹤0.01% |
20,109
+4,844
| +32% | +$234K |
|
|
UMPQ
1246
DELISTED
Umpqua Holdings Corp
UMPQ
| $1.02M | ﹤0.01% |
+48,900
| New | +$1.07M |
|
|
MNK
1247
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $997K | ﹤0.01% |
34,025
+21,321
| +168% | +$600K |
|
1248
CNA Financial
CNA
$14.7B
| $991K | ﹤0.01% |
21,700
-11,200
| -34% | -$518K |
|
1249
JD.com
JD
$41.1B
| $974K | ﹤0.01% |
37,322
-1,475
| -4% | -$48.3K |
|
1250
Ituran Location and Control
ITRN
$1.08B
| $966K | ﹤0.01% |
+28,093
| New | +$928K |
|
Similar funds
Janus Henderson Group's Q3 2018 Portfolio in Review
As of Q3 2018, Janus Henderson Group held 1,505 positions worth $187B, up 6.7% from $175B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Janus Henderson Group's Q3 2018 filing shows 118 new, 660 increased, 620 reduced and 63 closed positions. Its largest new stake was Elanco Animal Health: 1,976,916 shares worth $69M. The largest sale was Biogen, an estimated $372M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
- Janus Henderson Group's largest Q3 2018 buy was Elanco Animal Health: 1,976,916 shares worth $69M.
- Janus Henderson Group added most to Apple in Q3 2018, an estimated $686M increase.
- Janus Henderson Group's biggest Q3 2018 reduction was Biogen, cutting an estimated $372M.
- Janus Henderson Group fully exited Financial Engines, Inc. in Q3 2018, selling an estimated $190M.
- Janus Henderson Group's ten largest holdings make up 16% of its $187B portfolio in Q3 2018.
- Janus Henderson Group opened 118 new positions and closed 63 in Q3 2018.
- Janus Henderson Group's portfolio value rose 6.7% quarter-over-quarter to $187B.
Based on Janus Henderson Group's 13F filing for Q3 2018, filed 9 Nov 2018.